Login / Signup

Proteomics profiling of colorectal cancer progression identifies PLOD2 as a potential therapeutic target.

Yingkuan ShaoKailun XuXi ZhengBiting ZhouXiuli ZhangLin WangYaoting SunDan LiTing ChenJian WangShaojun YuLifeng SunXiaoming XuShaozhi DaiHuanhuan GaoGuan RuanWei LiuXue CaiTiansheng ZhuLina QiJiani ChenWangxiong HuXingyue WengYi ZhuXueping XiangZhiyuan HuJinfan LiLirong ChenJimin ShaoShu ZhengTiannan Guo
Published in: Cancer communications (London, England) (2021)
Keyphrases
  • mass spectrometry
  • genome wide
  • single cell
  • human health
  • label free
  • gene expression
  • dna methylation
  • risk assessment